Come up with a name for your new list and we'll add to it:
Aclairo Pharmaceutical Development Group was acquired by
Experimental Pathology Laboratories on January 13, 2016.
Aclairo's experience as FDA supervisors, reviewers, and industry strategists has forged a unique comprehension of the product-specific complexities of pharmaceutical development. The Company's advanta…